Pennvax-GP: Phase I started

Inovio said the HIV Vaccine Trials Network (HVTN) began a double-blind, placebo-controlled, dose-escalation, U.S. Phase I trial of Pennvax-GP plus an IL-12 DNA adjuvant given via intradermal or intra...